Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2019 16:35 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
January 24, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
January 22, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Further Expansion of Thyroid Business

Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms PARSIPPANY, NJ, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it...
January 14, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

Agreement Provides Access to Company’s Available Molecular Diagnostic Tests PARSIPPANY, NJ, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) has entered in to an...
December 27, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider

PARSIPPANY, NJ, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that CIO Applications, a publication focused on providing professionals with...
December 17, 2018 06:50 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®

BarreGEN® is Interpace’s Lead Molecular Diagnostic Pipeline Product for Barrett’s Esophagus Parsippany, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace”)...
November 28, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Launches New Websites

New Design to Enhance Branding and Expand Social Media Outreach PARSIPPANY, NJ, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) is pleased to announce the launch of...
November 26, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®

New Article in Peer-Reviewed Journal Highlights Important Role of PancraGEN® Testing PARSIPPANY, NJ, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
November 13, 2018 16:17 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Reports Third Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Conference Call Tuesday, November 13, 2018 at 4:30 pm ET PARSIPPANY, NJ,, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully integrated commercial and...
November 09, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Participate in 9th Annual Craig-Hallum Alpha Select Conference

PARSIPPANY, NJ, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that the Company has been invited to participate at the 9th Annual Craig-Hallum...